| Name | iclaprim |
|---|---|
| Synonyms |
Iclaprim
2,4-Pyrimidinediamine, 5-[(2-cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl]- 5-[(2-cyclopropyl-7,8-dimethoxy-2h-chromen-5-yl)methyl]pyrimidine-2,4-diamine 5-[(2-Cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]-2,4-pyrimidinediamine |
| Description | Iclaprim is a new selective bacterial Dihydrofolate inhibitor, which can inhibit the growth of S. aureus (MRSA) with an MIC90 of 0.06 mg/mL. |
|---|---|
| Related Catalog | |
| Target |
Dihydrofolate[1] |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 616.7±65.0 °C at 760 mmHg |
| Molecular Formula | C19H22N4O3 |
| Molecular Weight | 354.403 |
| Flash Point | 326.8±34.3 °C |
| Exact Mass | 354.169189 |
| PSA | 105.51000 |
| LogP | 2.20 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.666 |
| Storage condition | 2-8℃ |